Melville, NY (PRWEB) April 27, 2021
Cartessa Aesthetics is pleased to announce the recent closing of a $35MM capital raise to support its rapid expansion as one of the leading aesthetic device companies in North America. Cartessa Aesthetics, incorporated in 2017, has quickly established a leadership position in the robust domestic market for aesthetic equipment. “We’re excited at the opportunity to accelerate our expansion plans which include enhanced distribution, marketing endeavors, and continued rollouts of new technology to the North American marketplace,” says Founder and CEO Gabe Lubin.
Crestline Investors Inc. out of Fort Worth, Texas, offers direct lending services to high performing companies like Cartessa Aesthetics. “We at Crestline have been extremely impressed by the Cartessa leadership team as well as their explosive growth, even through challenging times. The company has a resilient business model and has proven their commitment to offering a better business model to aesthetic providers and their patients,” cites Marc Strauss, Managing Director of Crestline Inc.
The completion of the transaction offers Cartessa Aesthetics additional financial resources to expand its distribution network, increase marketing spend, as well as continue to innovate new and relevant technology to the North American market space.
About Cartessa Aesthetics, LLC.
Cartessa Aesthetics, LLC sources leading aesthetic medical devices for distribution to dermatologists, plastic surgeons, cosmetic physicians and medical spas.
Cartessa selects the most cutting-edge technologies that offer clinically proven efficacy, patient safety, and the best possible investment for patients and professionals.
Cartessa is the exclusive US and Canadian partner for Quanta Systems. The company’s portfolio also includes VirtueRF and PHYSIQ, Deka manufactured Motus AX & Motus AY, Tetra CO2 with CoolPeel and Luxea as well as Subnovii Advanced Plasma Technology and Skinwave.
About Crestline Investors, Inc.
Crestline Investors, Inc. founded in 1997 and based in Fort Worth, Texas, is an institutional alternative investment management firm. Crestline specializes in credit and opportunistic investments, including financing and restructuring solutions for mature private equity funds. In addition, the firm manages a multi-PM equity market-neutral hedge fund, and provides Beta and Hedging Solutions for Institutional clients. The company maintains affiliate offices in New York City, London, Toronto and Tokyo.